mometasone furoate and its Impurities

A prodrug of mometasone, which is a glucocorticoid used to treat inflammation, allergic rhinitis, and asthama. As a steroid it is more potent than testosterone. Reference standards of Mometasone Furoate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 34 results for mometasone furoate Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 13 60000

Mometasone Furoate

Mometasone Furoate


  • Catalogue No.:PA 13 60000

  • CAS :

    83919-23-7

  • Molecular Formula : C27H30Cl2O6

  • Molecular Weight : 521.44

Drug Reference Standards & Impurity Synthesis in India
PA 13 60010

Mometasone Furoate - Impurity A

21-Chloro-16α-methyl-3,20-dioxopregna-1,4,9(11)-trien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60010

  • CAS :

    83880-65-3

  • Molecular Formula : C27H29ClO5

  • Molecular Weight : 468.97

Drug Reference Standards & Impurity Synthesis in India
PA 13 60020

Mometasone Furoate - Impurity B

9-Chloro-17β-(2,2-dioxo-2,5-dihydro-1,2λ6 -oxathiol-4-yl)-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60020

  • CAS :

    223776-49-6

  • Molecular Formula : C28H31ClO8S

  • Molecular Weight : 563.06

Drug Reference Standards & Impurity Synthesis in India
PA 13 60030

Mometasone Furoate - Impurity C

21-Chloro-16α-methyl-3,11,20-trioxopregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60030

  • CAS :

    1305334-31-9

  • Molecular Formula : C27H29ClO6

  • Molecular Weight : 484.97

Drug Reference Standards & Impurity Synthesis in India
PA 13 60040

Mometasone Furoate - Impurity D

21-Chloro-9,11β-epoxy-16α-methyl-3,20-dioxo-9β-pregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60040

  • CAS :

    83881-09-8

  • Molecular Formula : C27H29ClO6

  • Molecular Weight : 484.97

Drug Reference Standards & Impurity Synthesis in India
PA 13 60050

Mometasone Furoate - Impurity E

9,21-Dichloro-16α-methyl-3,20-dioxopregna-1,4-diene-11β,17-diyl di(furan-2-carboxylate)


  • Catalogue No.:PA 13 60050

  • CAS :

    1370190-33-2

  • Molecular Formula : C32H32Cl2O8

  • Molecular Weight : 615.50

Drug Reference Standards & Impurity Synthesis in India
PA 13 60060

Mometasone Furoate - Impurity F

9,21-Dichloro-11β-hydroxy-16α-methyl-3,6,20-trioxopregna-1,4-dien-17-ylfuran-2-carboxylate


  • Catalogue No.:PA 13 60060

  • CAS :

    1305334-30-8

  • Molecular Formula : C27H28Cl2O7

  • Molecular Weight : 535.41

Drug Reference Standards & Impurity Synthesis in India
PA 13 60070

Mometasone Furoate - Impurity G

Mometasone


  • Catalogue No.:PA 13 60070

  • CAS :

    105102-22-5

  • Molecular Formula : C22H28Cl2O4

  • Molecular Weight : 427.36

Drug Reference Standards & Impurity Synthesis in India
PA 13 60080

Mometasone Furoate - Impurity H

9-Chloro-11β,21-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60080

  • CAS :

    148596-90-1

  • Molecular Formula : C27H31ClO7

  • Molecular Weight : 502.98

Drug Reference Standards & Impurity Synthesis in India
PA 13 60090

Mometasone Furoate - Impurity I

6ξ-Acetoxy-9,21-dichloro-11β-hydroxy-16α-methyl-3,20-dioxo-5ξ-pregn-1-en-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60090

  • CAS :

    NA

  • Molecular Formula : C29H34Cl2O8

  • Molecular Weight : 581.48

Drug Reference Standards & Impurity Synthesis in India
PA 13 60100

Mometasone Furoate - Impurity J

9,21-Dichloro-11β-hydroxy-6α,16α-dimethyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60100

  • CAS :

    NA

  • Molecular Formula : C28H32Cl2O6

  • Molecular Weight : 535.46

Drug Reference Standards & Impurity Synthesis in India
PA 13 60110

Mometasone Furoate - Impurity K

9-Chloro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione


  • Catalogue No.:PA 13 60110

  • CAS :

    4647-20-5

  • Molecular Formula : C22H29ClO5

  • Molecular Weight : 408.92

Drug Reference Standards & Impurity Synthesis in India
PA 13 60140

Mometasone Furoate - Impurity N

9-Chloro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl Methanesulfonate


  • Catalogue No.:PA 13 60140

  • CAS :

    352315-75-4

  • Molecular Formula : C23H31ClO7S

  • Molecular Weight : 487.01

Drug Reference Standards & Impurity Synthesis in India
PA 13 60150

Mometasone Furoate - Impurity O

9-Chloro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate


  • Catalogue No.:PA 13 60150

  • CAS :

    24916-91-4

  • Molecular Formula : C24H31ClO6

  • Molecular Weight : 450.95

Drug Reference Standards & Impurity Synthesis in India
PA 13 60180

Mometasone Furoate - Impurity R

9-Chloro-11β-hydroxy-16α-methyl-21-[(methylsulfonyl)oxy]-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60180

  • CAS :

    1370190-08-1

  • Molecular Formula : C28H33ClO9S

  • Molecular Weight : 581.07

Drug Reference Standards & Impurity Synthesis in India
PA 13 60190

Mometasone Furoate - Impurity S

9,21-Dichloro-11β-hydroxy-16β-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 60190

  • CAS :

    2231764-75-1

  • Molecular Formula : C27H30Cl2O6

  • Molecular Weight : 521.43

Drug Reference Standards & Impurity Synthesis in India
PA 13 60510

Mometasone Furoate - Impurity Q

21-Chloro-9,11ß-epoxy-17-hydroxy-16a-methyl-9ß-pregna-1,4-diene-3,20-dione


  • Catalogue No.:PA 13 60510

  • CAS :

    83881-08-7

  • Molecular Formula : C22H27ClO4

  • Molecular Weight : 390.90

Drug Reference Standards & Impurity Synthesis in India
PA 13 60540

Mometasone Furoate - Impurity L

9,11β-Epoxy-17,21-dihydroxy-16α-methyl-9β-pregna-1,4-diene-3,20-dione


  • Catalogue No.:PA 13 60540

  • CAS :

    24916-90-3

  • Molecular Formula : C22H28O5

  • Molecular Weight : 372.45

Drug Reference Standards & Impurity Synthesis in India
PA 13 60550

Mometasone Furoate - Impurity T

9,21-Dichloro-11β-hydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-17-yl 5-chlorofuran-2- carboxylate


  • Catalogue No.:PA 13 60550

  • CAS :

    NA

  • Molecular Formula : C27H29Cl3O6

  • Molecular Weight : 555.87

Drug Reference Standards & Impurity Synthesis in India
PA 13 60130

Mometasone Furoate - Impurity M

9-Chloro-11β,17-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione


  • Catalogue No.:PA 13 60130

  • CAS :

    57780-86-6

  • Molecular Formula : C22H29ClO4

  • Molecular Weight : 392.92

Drug Reference Standards & Impurity Synthesis in India
PA 13 0600160

Mometasone Furoate - Impurity P

9-Chloro-11β,17-dihydroxy-16α-methyl-3,20-dioxopregna-1,4-dien-21-yl furan-2-carboxylate


  • Catalogue No.:PA 13 0600160

  • CAS :

    NA

  • Molecular Formula : C27H31ClO7

  • Molecular Weight : 502.99

Drug Reference Standards & Impurity Synthesis in India
PAI 13 003130

(10S,13S,14S,16R,17R)-9-Bromo-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(10S,13S,14S,16R,17R)-9-Bromo-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PAI 13 003130

  • CAS :

    NA

  • Molecular Formula : C27H30BrClO6

  • Molecular Weight : 565.89

Drug Reference Standards & Impurity Synthesis in India
PAI 13 003131

(4aS,6aS,7R,8R)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-11-methylene-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one

(4aS,6aS,7R,8R)-7-Hydroxy-7-(2-hydroxyacetyl)-4a,6a,8-trimethyl-11-methylene-5a,6,6a,7,8,9,9a,9b,10,11-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-2(4aH)-one


  • Catalogue No.:PAI 13 003131

  • CAS :

    NA

  • Molecular Formula : C23H28O5

  • Molecular Weight : 384.47

Drug Reference Standards & Impurity Synthesis in India
PAI 13 003132

2-((4aS,6aS,7R,8R)-7-Hydroxy-4a,6a,8-trimethyl-11-methylene-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl acetate

2-((4aS,6aS,7R,8R)-7-Hydroxy-4a,6a,8-trimethyl-11-methylene-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl acetate


  • Catalogue No.:PAI 13 003132

  • CAS :

    NA

  • Molecular Formula : C25H30O6

  • Molecular Weight : 426.51

Drug Reference Standards & Impurity Synthesis in India
PAI 13 003133

2-((4aS,6aS,7R,8R)-7-Hydroxy-2-methoxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl Acetate

2-((4aS,6aS,7R,8R)-7-Hydroxy-2-methoxy-4a,6a,8-trimethyl-4a,5a,6,6a,7,8,9,9a,9b,10-decahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl Acetate


  • Catalogue No.:PAI 13 003133

  • CAS :

    NA

  • Molecular Formula : C25H32O6

  • Molecular Weight : 428.53

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601006

(16α)-21-Chloro-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione

(16α)-21-Chloro-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione


  • Catalogue No.:PA 13 0601006

  • CAS :

    151265-36-0

  • Molecular Formula : C22H27ClO3

  • Molecular Weight : 374.91

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601007

(11β)-21-(Acetyloxy)-9-bromo-11-hydroxypregna-1,4,16-triene-3,20-dione

(11β)-21-(Acetyloxy)-9-bromo-11-hydroxypregna-1,4,16-triene-3,20-dione


  • Catalogue No.:PA 13 0601007

  • CAS :

    131711-17-6

  • Molecular Formula : C23H27BrO5

  • Molecular Weight : 463.37

Drug Reference Standards & Impurity Synthesis in India
PAI 13 003134

(10S,13S,16R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-6-methylene-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(10S,13S,16R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-6-methylene-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PAI 13 003134

  • CAS :

    NA

  • Molecular Formula : C28H30Cl2O6

  • Molecular Weight : 533.44

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601008

(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-11-Hydroxy-17-(2-hydroxyacetyl)-13,16-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(8S,9R,10S,11S,13S,14S,16R,17R)-9-Chloro-11-Hydroxy-17-(2-hydroxyacetyl)-13,16-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 0601008

  • CAS :

    NA

  • Molecular Formula : C26H29ClO7

  • Molecular Weight : 488.96

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601009

(6S,9R,10S,11S,13S,16S,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-6,10,13,16-tetramethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(6S,9R,10S,11S,13S,16S,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-6,10,13,16-tetramethyl-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 0601009

  • CAS :

    NA

  • Molecular Formula : C28H34Cl2O6

  • Molecular Weight : 537.47

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601010

(8S,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-6-methylene-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(8S,10S,11S,13S,14S,16R,17R)-9-Chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-6-methylene-3-oxo-4,5,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 0601010

  • CAS :

    NA

  • Molecular Formula : C28H32Cl2O6

  • Molecular Weight : 535.46

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601011

Mometasone Furoate 21- Aldehyde impurity

Mometasone Furoate 21- Aldehyde impurity


  • Catalogue No.:PA 13 0601011

  • CAS :

    NA

  • Molecular Formula : C27H29ClO7

  • Molecular Weight : 500.97

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601012

2-((4aS,4bS,5aS,6aS,7R,8R,9aS,9bS)-7-Hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl 4-methylbenzenesulfonate

2-((4aS,4bS,5aS,6aS,7R,8R,9aS,9bS)-7-Hydroxy-4a,6a,8-trimethyl-2-oxo-2,4a,5a,6,6a,7,8,9,9a,9b,10,11-dodecahydrocyclopenta[1,2]phenanthro[4,4a-b]oxiren-7-yl)-2-oxoethyl 4-methylbenzenesulfonate


  • Catalogue No.:PA 13 0601012

  • CAS :

    201601-32-3

  • Molecular Formula : C29H34O7S

  • Molecular Weight : 526.64

Drug Reference Standards & Impurity Synthesis in India
PA 13 0601013

(8S,9R,10S,11S,13S,14S,16R,17R)-9,11-Dichloro-17-(2-chloroacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate

(8S,9R,10S,11S,13S,14S,16R,17R)-9,11-Dichloro-17-(2-chloroacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate


  • Catalogue No.:PA 13 0601013

  • CAS :

    NA

  • Molecular Formula : C27H29Cl3O5

  • Molecular Weight : 539.87

pharmaffiliates